MedPath

NOVO-OXCARBAZEPINE

NOVO-OXCARBAZEPINE

Discontinued
DIN Number

02312034

Drug Class

Human

Market Date

N/A

Company
HC

novopharm limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02312034
AIG Number0140461002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AF02 OXCARBAZEPINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

OXCARBAZEPINEActive
Strength: 300 MG
Monograph: OXCARBAZEPINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.